 |
市場調查報告書
商品編碼
1608860
去識別化健康資料市場：按資料類型、按應用、按最終用戶、按地區De-identified Health Data Market, By Type of Data, By Application, By End User, By Geography |
||||||
去識別化健康資料市場預計到 2024 年將達到 75.1 億美元，預計到 2031 年將達到 138 億美元，2024 年至 2031 年複合年成長率為 9.1%。
| 報告範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年 | 2023年 | 2024年市場規模 | 75.1億美元 |
| 實際資料 | 2019-2023 | 預測期 | 2024年至2031年 |
| 預測 2024-2031 年複合年成長率： | 9.10% | 2031 年金額預測 | 138億美元 |
去識別化醫療資料市場的成長是由藥物發現和精準醫學研發活動的增加所推動的。去身分化透過從健康資料集集中刪除姓名、出生日期和社會安全號碼等識別碼來確保病患的隱私和機密性。這使得研究人員和生命科學公司能夠在不損害道德的情況下利用大量健康資料來開發新治療方法和流行病學研究。隨著世界範圍內健康記錄數位化的加速，可供二次使用的去識別化資料量將會增加。
市場動態
對基於價值的護理、個人化護理以及數位醫療新興企業的成長的日益關注可能會推動全球對去識別化醫療資料的需求。然而，資料標準化的缺乏和知識產權的模糊性可能會阻礙市場潛力。高階分析功能的發展為企業提供了從匯集的資料資產中獲得更深入見解的機會。擴大政府開放資料共用舉措可以擴大對這些資料集的存取。美國政府推出了Data.gov 和 HealthData.gov 等舉措，提供對各種健康相關資料集集的開放訪問，以促進公共衛生研究的透明度和創新。
本研究的主要特點
本報告對全球去識別化健康資料市場進行了詳細分析，包括年複合成長率（CAGR%）。
它還揭示了各個細分市場的潛在商機，並說明了該市場有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
它根據公司亮點、產品系列、主要亮點、財務表現和策略等參數，介紹了全球去識別化健康資料市場的主要企業。
本研究涵蓋的主要企業包括 IQVIA、 Oracle(Cerner Corporation)、Merative (Truven Health Analytics)、Optum, Inc.、BioTelemetry, Inc.、Flatiron Health、Veradigm LLC、Medidata Solutions、Evidation Health, Inc.、Komodo Health , Inc.、Sundown Solutions, LLC、Clarify Health Solutions、Akrivia Health、Satori Cyber Ltd.、Tempus、nference、Ciox Health、HealthVerity、Zebra Medical Vision 和 Huma Therapeutics。
該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球去識別化健康資料市場報告針對該行業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
相關人員可以透過用於分析全球去識別醫療資料市場的各種策略矩陣來促進他們的決策。
目錄
第1章 研究目的與前提
- 研究目的
- 先決條件
- 簡稱
第2章 市場展望
- 報告說明
- 市場定義和範圍
- 執行摘要
第3章市場動態、法規及趨勢分析
- 市場動態
- 促進因素
- 抑制因素
- 機會
- 影響分析
- 主要進展
- 監管場景
- 產品發布/核准
- PEST分析
- 波特分析
- 併購場景
- 產業動態
第 4 章 去識別化健康資料市場，依資料類型分類，2019-2031
- 臨床資料
- 基因組資料
- 患者人口統計
- 處方資料
- 索賠資料
- 行為資料
- 穿戴式裝置和感測器資料
- 調查和患者報告的資料
- 影像資料
- 檢驗資料
- 健康的社會決定因素 (SDOH)資料
- 其他
第5章 去識別化健康資料市場，依應用分類，2019-2031
- 臨床研究和臨床實驗
- 公共衛生
- 精準醫療
- 衛生經濟學和結果研究（HEOR）
- 人口健康管理
- 藥物發現與開發
- 提高醫療保健品質
- 核保和風險評估
- 其他
第 6 章 去識別化健康資料市場，依最終使用者分類，2019-2031 年
- 製藥公司
- 生技公司
- 醫療服務提供方
- 保險公司/醫療保健付款人
- 研究所
- 政府機構
- 其他
第7章 去識別化健康資料市場，依地區分類，2019-2031
- 北美洲
- 拉丁美洲
- 歐洲
- 亞太地區
- 中東
- 非洲
第8章 競爭格局
- IQVIA
- Oracle（Cerner Corporation）
- Merative（Truven Health Analytics）
- Optum, Inc.
- BioTelemetry, Inc.
- Flatiron Health
- Veradigm LLC
- Medidata Solutions
- Evidation Health, Inc.
- Komodo Health, Inc.
- Sundown Solutions, LLC
- Clarify Health Solutions
- Akrivia Health
- Satori Cyber Ltd.
- Tempus
- nference
- Ciox Health
- HealthVerity
- Zebra Medical Vision
- Huma Therapeutics
第9章 分析師建議
- 命運之輪
- 分析師觀點
- 一致的機會圖
第10章 參考文獻與調查方法
- 參考
- 調查方法
- 關於出版商
De-identified health data market is estimated to be valued at USD 7.51 Bn in 2024 and is expected to reach USD 13.80 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 9.1% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | 7.51 Bn |
| Historical Data for: | 2019 to 2023 | Forecast Period: | 2024 to 2031 |
| Forecast Period 2024 to 2031 CAGR: | 9.10% | 2031 Value Projection: | 13.80 Bn |
De-identified health data market growth is driven by increasing research and development activities for drug discovery and precision medicine. De-identification ensures patient privacy and confidentiality by removing identifiers such as name, date of birth, social security number, and others from health data sets. This allows researchers and life science companies to utilize large pools of health data for developing novel therapies and epidemiological studies without compromising on ethics. As digitization of health records accelerates across the world, there will be increase in amount of de-identified data available for secondary usage.
Market Dynamics
Rising focus on value-based care, personalization of treatment, and growth of digital health startups can boost demand for de-identified health data globally. However, lack of data standardization and ambiguity over intellectual property rights can hamper the market potential. Development of advanced analytics capabilities offers an opportunity for players to unlock deeper insights from pooled data assets. Growing open data sharing initiatives by governments can widen the access to these data sets. The U.S. government has launched initiatives like Data.gov and HealthData.gov that offers open access to a wide range of health-related datasets to encourage transparency and innovation in public health research.
Key features of the study
This report provides in-depth analysis of the global de-identified health data market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global de-identified health data market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include IQVIA, Oracle (Cerner Corporation), Merative (Truven Health Analytics), Optum, Inc., BioTelemetry, Inc., Flatiron Health, Veradigm LLC, Medidata Solutions, Evidation Health, Inc., Komodo Health, Inc., Sundown Solutions, LLC, Clarify Health Solutions, Akrivia Health, Satori Cyber Ltd., Tempus, nference, Ciox Health, HealthVerity, Zebra Medical Vision, and Huma Therapeutics
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global de-identified health data market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global de-identified health data market
Market Segmentation
- Type of Data Insights (Revenue, USD Bn, 2019 - 2031)
- Clinical Data
- Genomic Data
- Patient Demographics
- Prescription Data
- Claims Data
- Behavioral Data
- Wearable and Sensor Data
- Survey and Patient-Reported Data
- Imaging Data
- Laboratory Data
- Social Determinants of Health (SDOH) Data
- Others
- Application Insights (Revenue, USD Bn, 2019 - 2031)
- Clinical Research and Trials
- Public Health
- Precision Medicine
- Health Economics and Outcomes Research (HEOR)
- Population Health Management
- Drug Discovery and Development
- Healthcare Quality Improvement
- Insurance Underwriting and Risk Assessment
- Others
- End User Insights (Revenue, USD Bn, 2019 - 2031)
- Pharmaceutical Companies
- Biotechnology Firms
- Healthcare Providers
- Insurance Companies/Healthcare Payers
- Research Institutions
- Government Agencies
- Others
- Regional Insights (Revenue, USD Bn, 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- IQVIA
- Oracle (Cerner Corporation)
- Merative (Truven Health Analytics)
- Optum, Inc.
- BioTelemetry, Inc.
- Flatiron Health
- Veradigm LLC
- Medidata Solutions
- Evidation Health, Inc.
- Komodo Health, Inc.
- Sundown Solutions, LLC
- Clarify Health Solutions
- Akrivia Health
- Satori Cyber Ltd.
- Tempus
- nference
- Ciox Health
- HealthVerity
- Zebra Medical Vision
- Huma Therapeutics
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- De-identified Health Data Market, By Type of Data
- De-identified Health Data Market, By Application
- De-identified Health Data Market, By End User
- De-identified Health Data Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. De-identified Health Data Market, By Type of Data, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Clinical Data
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Genomic Data
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Patient Demographics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Prescription Data
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Claims Data
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Behavioral Data
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Wearable and Sensor Data
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Survey and Patient-Reported Data
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Imaging Data
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Laboratory Data
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Social Determinants of Health (SDOH) Data
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
5. De-identified Health Data Market, By Application, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Clinical Research and Trials
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Public Health
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Precision Medicine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Health Economics and Outcomes Research (HEOR)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Population Health Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Drug Discovery and Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Healthcare Quality Improvement
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Insurance Underwriting and Risk Assessment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
6. De-identified Health Data Market, By End User, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Pharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Biotechnology Firms
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Healthcare Providers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Insurance Companies/Healthcare Payers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Research Institutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Government Agencies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
7. De-identified Health Data Market, By Region, 2019 - 2031, (USD Bn)
- Introduction
- Market Share (%) Analysis, 2024,2027 & 2031, (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2020 - 2031, (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Type of Data, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Type of Data, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Type of Data, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Type of Data, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Type of Data, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Type of Data, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country/Region, 2019 - 2031, (USD Bn)
- South Africa
- North Africa
- Central Africa
8. Competitive landscape
- IQVIA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Oracle (Cerner Corporation)
- Merative (Truven Health Analytics)
- Optum, Inc.
- BioTelemetry, Inc.
- Flatiron Health
- Veradigm LLC
- Medidata Solutions
- Evidation Health, Inc.
- Komodo Health, Inc.
- Sundown Solutions, LLC
- Clarify Health Solutions
- Akrivia Health
- Satori Cyber Ltd.
- Tempus
- nference
- Ciox Health
- HealthVerity
- Zebra Medical Vision
- Huma Therapeutics
9. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
10. References and Research Methodology
- References
- Research Methodology
- About us
